The U.S. Department of Labor Urges Second Circuit to Deny FLSA Overtime Exemptions to Pharmaceutical Sales Representatives
On October 14, 2009, the U.S. Department of Labor (“DOL”) filed an amicus brief in a case pending before the Second Circuit Court of Appeals, In Re Novartis Wage and Hour Litigation, arguing for a stricter interpretation of “outside salesperson” and “administrative employee” exemptions under the federal Fair Labor Standards Act, as applied to pharmaceutical sales representatives. In its brief, the DOL maintains that pharmaceutical sales representatives neither “make sales” nor exercise sufficient discretion to qualify for the exemptions from overtime compensation, urging the Court of Appeals to reverse the district court’s defense judgment below. See In Re Novartis Wage and Hour Litig., 593 F. Supp. 2d 637, 640 (S.D.N.Y. 2009).

